Cornell inventors are turning visionary ideas into tangible solutions to global challenges. Cornell’s Center for Technology Licensing celebrated their achievements at its inaugural Bearers of Innovation event.
Before a cell commits fully to the process of dividing itself into two new cells, it may ensure the appropriateness of its commitment by staying for many hours – sometimes more than a day – in a reversible intermediate state, according to new research.
TeraPore Technologies, co-founded by Rachel Dorin, Ph.D. ’13, and its novel nanofiltration products are changing how the pharmaceutical industry is reducing risk of harmful virus contamination in biological drugs.
Wildlife experts have developed a regional computer model – and user friendly app – that predicts counties where wildlife managers should target their surveillance of chronic wasting disease in deer.
A study involving more than 3.6 million people who’d already received COVID vaccinations found that offering free Lyft rides to a vaccination site was no more enticing than simply reminding people of the importance of getting boosted.
Weill Cornell Medicine received a $1.5 million grant to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
Nutritionists generally advise everyone to eat more dietary fiber, but a new study suggests that its effects on health can vary, suggesting that recommendations should be tailored to each individual’s gut microbiome.
Intimate partner violence is notoriously underreported and correctly diagnosed at hospitals only around a quarter of the time, but a new method provides a more realistic picture of which groups of women are most affected, even when their cases go unrecorded.
